Tau hyperphosphorylation in apolipoprotein E-deficient and control mice after closed head injury

Journal of Neuroscience Research

Volumn 60, Issue 4, 2000, Pages 559-564

  Genis, L ^a   Chen, Y ^b   Shohami, E ^b   Michaelson, Daniel M ^a  

^a TEL AVIV UNIVERSITY   (Israel)

^b HEBREW UNIVERSITY OF JERUSALEM   (Israel)

Author keywords

Alzheimer disease; Apolipoprotein E; Closed head injury; Microtubule associated protein tau; Phosphorylation

Indexed keywords

APOLIPOPROTEIN E; CYTOSKELETON PROTEIN; TAU PROTEIN;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; HEAD INJURY; HYPERLIPOPROTEINEMIA TYPE 3; LEARNING; MALE; MEMORY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN PHOSPHORYLATION;

ANIMALS; APOLIPOPROTEINS E; BRAIN CHEMISTRY; BRAIN INJURIES; CYTOSKELETAL PROTEINS; EPITOPES; HEAD INJURIES, CLOSED; IMMUNOBLOTTING; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; PHOSPHORYLATION; PROSENCEPHALON; TAU PROTEINS; TIME FACTORS;

EID: 0034657814     PISSN: 03604012     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4547(20000515)60:4<559::AID-JNR15>3.0.CO;2-K     Document Type: Article

References (24)

1. Biernat J, Gustke N, Drewes G, Mandelkow EM, Mandelkow E. 1993. Phosphorylation of Ser 262 strongly reduces binding of tau to microtubules: distinction between PHF-tau immunoreactivity and microtubule binding. Neuron 11:153-163.
2. Bramblett GT, Goedert M, Jakes R, Merrick SE, Trojanowski JQ, Lee VM-Y. 1993. Abnormal tau phosphorylation at Ser 396 in Alzheimer disease recapitulates development and contributes to reduced microtubule binding. Neuron 10:1089-1099.
3. Brion J-P, Couck A-M, Robertson J, Loving TLF, Anderton BH. 1993. Neurofilament monoclonal antibodies RT97 and 8D8 recognize different modified epitopes in paired helical filament tau in Alzheimer disease. J Neurochem 60:1372-1382.
4. Chapman S, Michaelson DM. 1998. Specific neurochemical derangements of brain projecting neurons in apolipoprotein E-deficient mice. J Neurochem 70:708-714.
5. Chen Y, Lomnitzki L, Michaelson DM, Shohami E. 1997. Motor and cognitive deficits in apolipoprotein E-deficient mice after closed head injury. Neurosci 80:1255-1262.
6. Genis I, Gordon I, Sehayek E, Michaelson DM. 1995. Phosphorylation of tan in apolipoprotein E-deficicnt mice. Neurosci Lett 199:5-8.
7. Genis I, Fisher A, Michaelson DM. 1999. Site-specific dephosphorylation of tau of apoE deficient and control mice by M1 muscarinic agonist treatment. J Neurochem 72:206-213.
8. Goedert M. 1993 Tau protein and the neurofibrillary pathology of Alzheinier disease. Trends Neurochem 11:460-465.
9. Goedert M, Jakes R, Crowther RA, Cohen P, Vanmechelen E, Vandermeeren M, Cras V. 1994. Epitope mapping of monoclonal antibodies to the paired helical filaments of Alzhemier's disease: identification of phosphorylation sites in tau. Biochem J 301:871-877.
10. Goedert M, Hasegawa M, Jakes R, Lawler S, Cuenda A, Cohen P. 1997. Phosphorylation of microtubule-associated protein tau by stress-activated protein kinases. FEBS Lett 409:57-62.
11. Gordon I, Grauer E, Genis I, Sehayek E, Michaelson DM. 1995. Memory deficits and cholinergic impairment in apolipoprotein E-deficient mice. Neurosci Lett 199:1-4.
12. Kosik KS, Greenberg SM. 1994. Tau protein and Alzheimer disease. In: Terry RD, Katzman P, Bick KL, editors. Alzheimer Disease. New York: Raven Press Ltd. p 335-344.
13. Kosik K, Orecchio I, Binder L, Trokanowski J, La V, La G. 1988. Epitopes that span the tau molecule are shared with paired helical filaments. Neuron 1:817-825.
14. Laskowitz DT, Matthew WD, Bennett ER, Schmechel D, Herbstreith MH, Goel S, McMillian MK. 1998. Endogenous apolipoprotein E suppresses EPS-stimulated microglial nitric oxide production. NeuroReport 9:615-618.
15. Lomnitski L, Chapman S, Hochman A, Kohen R, Shohami E, Chen Y, Trembovler V, Michaelson DM 1999. Antioxidant mechanisms in apolipoprotein E deficient mice prior to and following closed head injury. Biochim Biophys Acta 1453:359-368.
16. Mandelkow EM, Mandelkow E. 1993. Tau as a marker for Alzheimer disease. Trends Biochem Sci 18:480-483.
17. Mawal-Dewan M, Henley J, Van de Voorde A, Trojanowski JQ, Lee VM. 1994. The phosphorylation state of tau in the developing rat brain is regulated by phospho-protein phosphatase. J Biol Chem 269:30981-30987.
18. Mercken M, Vandermeeren M, Lubke U, Six J, Bioos J, Van de Voorda A, Martin JJ, Gheuen J. 1992. Monoclonal antibodies with selective specificity for Alzheimer tau are directed against phosphatase-sensitive epitope. Acta Neuropathol 84:262-272.
19. Plump AS, Smith JD, Hayek T, Aalto-Setala K, Walsh A, Verstuyft JG, Rubin EM, Breslaw JL. 1992. Severe hypercholesterolemia and athero-sclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells. Cell 71:343-353.
20. Poirier J. 1995. Apolipoprotein E in animal models of CNS injury and in Alzheimer disease. Trends Neurosci 17:525-530.
21. Reynolds CH, Nebreda AR, Gibb GM, Litton MA., Anderton BH. 1997. Reactivating kinase/p38 phosphorylates tau protein in vitro. J Neurochem 69:191-198.
22. Roses AD. 1994. Apolipoprotein E is a genetic locus that affects the role of Alzheimer disease expression: amyloid burden is a secondary consequence dependent on apoE genotype and duration of disease. J Neuropathol Exp Neurol 53:429-437.
23. Strittmatter WJ, Saunders AM, Goedert M, Weisgraber KH, Dong LM, Jacks R, Huang DY, Schmechel D, Pericak-Vance M, Roses AD. 1994. Isoform specific interaction of apolipoprotein E with the microtubule-associated protein tau: implications for Alzheimer disease. Proc Natl Acad Sci USA 91:243-249.
24. Zelman FP, Dean GE. 1996. Monoclonal antibody PHF1 recognizes phosphorylated serine 404 of tau protein and labels paired helical filaments. J Neurosci Res 46:90-97.